Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder
Clinical trial NCT03169816 · COMPLETED
Trial details
- NCT number
- NCT03169816
- Sponsor
- New York State Psychiatric Institute
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-25
- Primary completion
- 2019-08-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.